Milan, Lombardy, Italy
After years in global leadership roles within the pharmaceutical industry, I chose to extend this work beyond organizational boundaries, embracing a more direct, independent engagement in health and healthcare communication, education, and consulting. Today, I operate at the intersection of science, ethics, and real-world healthcare impact, focusing on how health communication, medical education and pharma can meaningfully improve patient outcomes, health literacy, informed decision-making, and quality of life. I collaborate across academic, non-profit, and organizational contexts, supporting initiatives that place patients and caregivers at the center, while ensuring scientific rigor and operational sustainability. My perspective is shaped by long-term, hands-on experience navigating complex care ecosystems and coordinating multidisciplinary care pathways, anchoring my work in real-world applicability, ethical responsibility, and long-term impact for patients and their families. This independent work builds on extensive global leadership experience in healthcare and pharmaceuticals, spanning integrated marketing, business development, brand and portfolio strategy, product launches and lifecycle management, and strategic partnerships across multiple medical specialties, including Dermatology, Plastic Surgery, Aesthetic Medicine, Bariatric Medicine, Maxillofacial Surgery, Physical Medicine & Rehabilitation, and Neurology. I have led global teams, collaborated closely with C-level stakeholders and world-renowned Key Opinion Leaders, and operated across diverse geographies - including Europe, the US, Canada, LATAM, Russia, MEA, and Australia - balancing scientific value, patient needs, and organizational objectives. I am committed to fostering patient-centered advancement within healthcare systems through science, innovation, medical education, awareness raising and optimal healthcare communication.
Leveraging global pharmaceutical leadership experience to support innovation and transformation initiatives through collaborative, multi-stakeholder processes • Advising and engaging with pharmaceutical organizations on innovation strategy, stakeholder alignment, and complex decision-making • Catalyzing strategic dialogue at international level through structured collaborative methodologies • Contributing to transformation initiatives grounded in human-centric, behavioral and psychological insights
Working across health education, patient-centric initiatives, and science communication to bridge clinical expertise, lived experience, and societal understanding of health and wellbeing, in collaboration with academic, non-profit, and professional contexts. Activities include: • Development of health education and medical communication initiatives for non-medical audiences • Pro bono and advisory contributions to global medical education programs with international clinical and academic leaders • Design and moderation of expert dialogues, interviews, and public-facing conversations with healthcare professionals • Strategic advisory in healthcare communication, ethics, patient engagement, and informed decision-making • Contribution to international healthcare education and communication initiatives across Italian and global settings Focus areas: patient empowerment, patient-centered, ethical and accessible healthcare communication, high-impact medical education, prevention, and health literacy, aimed at delivering sustainable benefits for health, wellbeing, and quality-of-life outcomes. Engaged in advanced, interdisciplinary academic training in health communication, behavioural science, and wellbeing-related disciplines through executive programs and institutional courses.
Transitioned from Aesthetics to Therapeutics to lead the global transformation of Dysport®, driving sustained growth through end-to-end strategy, deep insights, and the design and execution of innovative, high-impact programs across key indications - laying a strong foundation for future pipeline success. • Led initiatives to sharpen brand essence and positioning, deliver integrated global messaging, and launch impactful global campaigns and HCP programs • Led the relaunch of Ixcellence®, the global HCP training program, positioning it as a strategic lever for brand experience and preference (launched at Toxins 2024 and Expert Training Forum 2024), in partnership with GMA • Developed and executed global brand plans (2021–2023), co-created the new cross-indication campaign (2022), and supported the NDO indication launch • Spearheaded patient journey projects (e.g., PSS), addressed data gaps, and supported segmentation strategy • Acted as Global Brand Lead a.i. (Jul–Dec 2021), contributing to +14.5% growth in 2023 (CAGR excl. 2020: +6%), with continued double-digit growth into 2024–2025 • Guided affiliates (notably US, Australia, EU4+UK, Brazil, Russia, Canada) and coordinated 3 internal and 2 external resources • Served as global commercial lead for major congresses: Toxins (2022, 2024), ISPRM (2022–2024), AAN (2023) • Recognized for excellence: 125% personal objectives achievement (2021), multiple over-performance years (2022–2024), and Global Leadership Team award for embodying “Ipsen Ways of Being”
Led global marketing strategy and execution for the Aesthetic Neuroscience portfolio, overseeing brand planning, campaign development, medical education, and market readiness. Partnered with affiliates and distributors to drive performance and consistency across regions. • Directed global brand planning processes and supported affiliate execution through country business reviews and marketing alignment • Launched the Ipsen Aesthetic Academy, establishing a cross-franchise best practice in medical education and achieving top KPI scores • Rolled out Ipsen’s first global aesthetic webinar series (2020), engaging ~1,000 participants per session across 32 countries • Drove the launch of the first liquid botulinum toxin in Western markets in partnership with Galderma, including GTM strategy, global campaign, pricing, and commercial policy • Piloted successful Key Account Management programs in Russia and Greece • Supported market research for future toxin development and contributed to internal visibility of Aesthetics through global communication initiatives • Achieved +6.1% global sales growth in 2020 despite COVID-19 challenges
Led global initiatives to grow the Aesthetic business within the Neuroscience franchise, driving marketing strategy, operational planning, and medical education across HQ and affiliates. Provided strategic guidance to key markets to elevate in-field execution and supported distributor coordination across high-potential geographies. • Played a key role in the creation of the Aesthetic Global Brand Team, engaging Business Unit Heads from top affiliates and regional brand leaders • Led the design and rollout of the first globally driven country operational planning process for Aesthetics, successfully adopted by all direct affiliates and distributors • Drove value-added selling pilots in priority markets (Russia, Greece), setting a precedent within the Neuroscience franchise • Core member of the Global Aesthetic Task Force, shaping a dedicated aesthetic business structure and supporting successful market launches in high-growth regions
• Designed and facilitated collaborative innovation journeys, enhancing collective intelligence across teams. • Developed and implemented “collaboraction” labs, driving exponential transformation in the pharmaceutical, healthcare, and beauty sectors. • Advised organizations on co-creation techniques, resulting in improved engagement and maximized innovation outcomes.
Managed Italy’s medical education programs, driving Key Opinion Leader (KOL) engagement, talent development, and professional education strategies to enhance loyalty and expand market presence. Played a key role in amplifying Italy’s contribution to global initiatives such as SKU positioning, advisory boards, and international clinical studies. Led collaborations with international KOLs and scientific societies, overseeing budgets to maximize program effectiveness. Successfully spearheaded the EMEA launch of an innovative anatomy digital training device developed by New York-based SHELD Innovation and Education Center (Verona, 2018).
Led marketing and brand management for the Aesthetic Business Unit, overseeing strategic marketing planning, medical events, and Key Opinion Leader (KOL) engagement. Directed the strategic repositioning of flagship brands with full budget accountability. • Exceeded 2017 sales and marketing targets, achieving 107% of goals • Successfully relaunched the portfolio by building a high-impact KOL leadership group and expanding a growing testimonial network • Initiated innovative co-creation programs, including design thinking methodologies, later adopted globally • Delivered highest satisfaction ratings across sales force and medical training initiatives